Peter M.A. Calverley

Sep 12, 2024 | erj.ersjournals.com | Peter M.A. Calverley

FootnotesConflict of interest: P.M.A. Calverley reports receiving grants, personal fees and non-financial support from pharmaceutical companies that make medicines to treat respiratory disease. This includes reimbursement for educational activities and advisory work, and support to attend meetings. Received June 13, 2024. Accepted June 13, 2024. View Full Text ERS Members myERS - ERS members : log in with your myERS username and password.

Nov 30, 2023 | books.ersjournals.com | Peter M.A. Calverley |Hilary Pinnock |Vitalii Poberezhets |David Drummond

By Peter M.A. Calverley 10.1183/2312508X.10017023 By Hilary Pinnock, Vitalii Poberezhets and David Drummond 10.1183/2312508X.10016623 By Alessandra Angelucci and Andrea Aliverti 10.1183/2312508X.10000423 By Amelia Licari, Giuliana Ferrante, Velia Malizia, Agnese Augello and Stefania La Grutta 10.1183/2312508X.10000523 By Isaac Cano, Ebymar Arismendi and Xavier Borrat 10.1183/2312508X.10000623 By Aniek F. Markus, Johnmary T. Arinze and Katia M.C. Verhamme 10.1183/2312508X.10000723 By...

Jun 1, 2023 | books.ersjournals.com | Peter M.A. Calverley |Thomas Wagner |Marc Humbert |Marlies S Wijsenbeek

Diagnosing rare diseases can be challenging, and treating these conditions is complex because of their often quite specific needs and treatment options. To address this, the European Respiratory Society (ERS) has published Rare Diseases of the Respiratory System.